Remember Testicular Cancer in Movember - Men's Health Awareness Month

From Don’t Give Up on Testicular Cancer · 16:06

Show by The Max Mallory Foundation - Joyce Lofstrom host

Men's Health Awareness Month Update: Testicular Cancer Stats, Symptoms, and Treatment TopicsIt's been a few months since Don't Give Up on Testicular Cancer went live, but the podcast is back. Joyce Lofstrom, host of the Max Mallory Foundation's "Don't Give Up on Testicular Cancer," records a solo November episode for Men's Health Awareness Month, sharing reminders, news, and personal reflections on testicular cancer. Citing American Cancer Society and NCI SEER data, she notes an expected 9,810 new U.S. cases and 630 deaths in 2026. She emphasizes a 95% cure rate when caught early, contrasted with common delays of two to three months before seeking care. She discusses Max Mallory's case (lower back pain, undescended testicle, choriocarcinoma) and highlights higher incidence in parts of central/southern Europe. She mentions public awareness efforts, including Will Reeve's disclosure about his testicular cancer. And finally, she reviews treatment topics including cisplatin long-term toxicities, surveillance vs. chemotherapy for low-risk patients, and timing for high-dose chemotherapy with stem cell rescue for high-risk or relapse cases.Timeline00:00 Podcast Introduction01:15 Men's Health Month Update02:13 Key U.S. Testicular Cancer Stats03:20 Max's Story and Delayed Care04:24 Global Trends and Self Exams06:38 Cancer Rise and New Vaccines07:50 Chemo Toxicity and Surveillance09:13 Risk Delays and High Dose Options13:02 Choriocarcinoma Symptoms and Vigilance14:32 Personal Reflections and Closing Thanks15:19 Subscribe and Foundation InfoSend us Fan MailSupport the showFind us on Twitter, Instagram, Facebook & Linkedin. If you can please support our nonprofit through Patreon.

More episodes of Don’t Give Up on Testicular Cancer

More episodes

PodSearch is a free, independent podcast search engine. Read about PodSearch, the privacy policy or contact us.